Navigation Links
HealthSouth Reports Results for Fourth Quarter Ended December 31, 2007
Date:2/25/2008

p>

Long-term debt, net of current

portion 1,974.4 3,343.1

Other long-term liabilities 175.6 282.2

3,120.5 4,886.9

Commitments and contingencies

Minority interest in equity of

consolidated affiliates 97.2 271.1

Convertible perpetual preferred stock 387.4 387.4

Shareholders' deficit:

Total shareholders' deficit (1,554.5) (2,184.6)

Total liabilities and shareholders'

deficit $2,050.6 $3,360.8

HealthSouth Corporation and Subsidiaries

Condensed Consolidated Statements of Cash Flows

(In Millions)

Year Ended

December 31,

2007 2006

Net cash provided by (used in)

operating activities $230.7 $(129.8)

Net cash provided by investing

activities 1,184.5 61.9

Net cash used in financing activities (1,436.6) (69.8)

Effect of exchange rate changes on

cash and cash equivalents 0.1 0.1

Decrease in cash and cash equivalents (21.3) (137.6)

Cash and cash equivalents at

beginning of year 27.1 166.6

Cash and cash equivalents of

divisions and facilities held for

sale at beginning of year 14.4 12.5

Less: Cash and cash equivalents of

divisions
'/>"/>

SOURCE HealthSouth Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22

Related medicine news :

1. HealthSouth Declares Dividend on 6.5% Series A Convertible Perpetual Preferred Stock
2. HealthSouth Issues Statement on Medicare Bill and 75% Rule
3. HealthSouth Announces Final Agreement on Previously Disclosed Settlement with Federal Government
4. HealthSouth and Physicians Pay $14.9 Million to Settle Health Care Fraud Claims
5. HealthSouth Announces Date of Third Quarter Earnings Conference Call
6. HealthSouth Corporation Appoints New Member to Board of Directors
7. HealthSouth Declares Dividend on 6.5% Series A Convertible Perpetual Preferred Stock
8. NHP Reports Fourth Quarter and Full Year 2007 Earnings
9. High Calcium Intake May Not Help Prevent Fractures, Reports The Harvard Health Letter
10. Clarity for Consumers on Botox Complication and Death Reports
11. Neurochem reports results for fourth quarter and fiscal year 2007 and important advances on corporate objectives
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2008)... Mich., Aug. 29 /PRNewswire/ -- In response to rec... chronic wasting disease (CWD),members of the dee...ement., With hunting season fast approaching, the... a deer on a Kent County farm understandably has,c...and deer farmers across,the great state of Michiga...
(Date:8/29/2008)...esults of a 10-year study published in the August ...found that magnesium sulfate administered to women...he risk of cerebral palsy by 50 percent. The Benef...) trial was conducted in 18 centers in the U.S., i...renatal intervention ever found to reduce the inst...
(Date:8/29/2008)... Trusted life science software provid...ents to engage via GSA. , ...ns, an emerging software engineering firm dedicat...U.S. General Services Administration (GSA) Contrac...omers with the ability to conveniently engage 5AM ...
(Date:8/28/2008)... will lead clinical efforts of the Maryland Medica.../ -- KePRO, a national medical,management firm, ap...of,Medical Director. Dr. Lawyer will oversee all c...rmed in KePRO,s Hunt Valley, Maryland Harrisburg,o...cal career in Maryland," said,Alice Stollenwerk Pe...
Breaking Medicine News(10 mins):Health News:Deer Farm Industry in Michigan Issues Statement on the Recent Chronic Wasting Disease Case Identified on a Kent County Deer Farm 2Health News:National study shows magensium sulfate reduces risk of cerebral palsy in premature births 2Health News:Federal and State Agencies Have Easier Access to 5AM Solutions' Award-Winning Software Services 2Health News:Lenaye Lawyer, MD, FACOG, Named KePRO Medical Director 2
...er retinoblastoma has been developed by scientists...nstrated// in a mouse model to cause a remarkable ...g the side effects common with standard chemothera...suitable for certain forms of breast, lung, prosta...
...ive pulmonary disease (COPD) attempt to repair dam...s finding is in contradiction with the convention...he finding is important because it could pave the ...on' key genes to allow the lung to grow new alveol...
...haviors of human beings has found that concerns ov...are unfounded.// Monogamy is still held in esteem ...y are published in The Lancet. The research has g...ch found that people were in single relationships ...
... tackled by more action and less talk according to...ter// voiced support for higher taxes on drinks. ...cottish Health Action on Alcohol Problems (SHAAP) ...alth problems and push for action to cut alcohol m...
Other Medicine News:Health News:Revolutionary Eye Cancer Treatment 2Health News:Revolutionary Eye Cancer Treatment 3Health News:Revolutionary Eye Cancer Treatment 4Health News:Lungs repair themselves 2Health News:Alcohol Abuse Must be solved with Action 2
(Date:8/28/2008)...ug. 28 /PRNewswire-USNewswire/ -- Blood transfusio...dicine, but can come with the risk,of donor diseas...ng the,biology of blood products to understand how...reduce this risk during blood transfusions.,Accord...od, the official,journal of the American Society o...
(Date:8/27/2008)...orial Hospital one of 18 centers involved in 10-ye.../ -- Results of a 10-year study,published in the A...ine,found that magnesium sulfate administered to w...ed the risk of cerebral palsy by 50 percent. The,B...BEAM) trial was,conducted in 18 centers in the U.S...
(Date:8/27/2008)...nized Pediatric Heart Center at The Children,s Hos...ty to Complete Range of Care and ...iatric Cardiology Team Treats Every Heart Conditio...he Children,s Hospital at,Montefiore (CHAM) is bri...plantation to the Bronx, following the recent appr...
(Date:8/26/2008)... Aug. 26 /- Semafore Pharmaceuticals ...national Congress on Targeted,Therapies in Cancer ...enic,activity of vascular-targeted PI3 kinase (PI3... signaling., PI3K is part of a very powerful path... to play a major role in cancer. Studies have show...
Breaking Medicine Technology:Variant of Mad Cow Disease May Be Transmitted by Blood Transfusions, According to Animal Study 2Variant of Mad Cow Disease May Be Transmitted by Blood Transfusions, According to Animal Study 3National Study Shows Magnesium Sulfate Reduces Risk of Cerebral Palsy in Premature Births 2National Study Shows Magnesium Sulfate Reduces Risk of Cerebral Palsy in Premature Births 3Pediatric Heart Transplants at Montefiore Approved by NY State Department of Health 2Pediatric Heart Transplants at Montefiore Approved by NY State Department of Health 3Pediatric Heart Transplants at Montefiore Approved by NY State Department of Health 4SF1126, Semafore's PI3 Kinase Inhibitor, Found to Block Angiogenic Signaling From Both VEGF and Bv8 in Multiple Cell Lines 2SF1126, Semafore's PI3 Kinase Inhibitor, Found to Block Angiogenic Signaling From Both VEGF and Bv8 in Multiple Cell Lines 3Tacere Therapeutics Enters Collaboration and License Agreement With Pfizer To Develop and Commercialize RNAi Hepatitis C Drug 1147 1Tacere Therapeutics Enters Collaboration and License Agreement With Pfizer To Develop and Commercialize RNAi Hepatitis C Drug 1147 2CSIC and UAB will build the most advanced superconductor cable for electricity network 1794 1CSIC and UAB will build the most advanced superconductor cable for electricity network 1794 2CSIC and UAB will build the most advanced superconductor cable for electricity network 1794 3Bacterial infections in premature babies more common than previously realized 1791 1Bacterial infections in premature babies more common than previously realized 1791 2Smallpox vaccine alternative identified 9140 1Smallpox vaccine alternative identified 9140 2
...- Data from Phase III pivotal trial demonstrate sa...formoterol fumarate for,patients with moderate to ...wire/ -- Dey, L.P. announced,that two clinical dat... Conference of the American Thoracic Society (ATS)...rancisco. The,presentations will detail Phase III ...
...HITEHOUSE STATION, N.J.--(BUSINESS WIRE)--May 17, ...how that Merck,s cervical cancer,vaccine, GARDASIL...16, 18) Recombinant Vaccine) was 100 percent effec...ysplasias caused by HPV,types 16 and 18, two types...percent protection was observed in women who were ...
Other Medicine Technology:Clinical Trial Data for Perforomist Inhalation Solution to be,Presented at ATS on May 20, 2007 2Clinical Trial Data for Perforomist Inhalation Solution to be,Presented at ATS on May 20, 2007 3Clinical Trial Data for Perforomist Inhalation Solution to be,Presented at ATS on May 20, 2007 4Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 2Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 3Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 4Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 5Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 6Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 7Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 8Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 9Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 10Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 11Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 12Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 13Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 14Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 15Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 16Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 17Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 18Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 19Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 20Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 21Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 22Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 23Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 24Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 25Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 26Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 27Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 28Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 29Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 30Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 31Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 32
...ny positive attributes of the IMMULITE 2000, the I...of Logic Driven Incubation (LDI). Using a newly de...be formatted for optimal performance with the fast...ssays, such as Siemens Diagnostics' cardiac biomar...
...ulated Screw System is part of a series of modular...ews ranging from 3.5 to 8.0 mm. Matching a combina...on, the system provides convenience and flexibilit...e 3.5/4.0 mm system may be customized using two of...
...rs a wide variety of cannulated screw products. Mo...eaded and fully threaded versions. , ,Our newer im...se incorporate innovative instrument designs to ma...wdrivers have proven to be a popular addition, esp...
...al Nailing System is one of the first humeral nail...rade or a retrograde approach to repair fractures ... now created a new generation locking nail system,...ts of separate antegrade and retrograde nailing sy...
Medicine Products: